Last reviewed · How we verify
NCT04270448
Effects of Feedback on Learning of a Motor Sequence Task
NA trial testing Motor Sequence Task in Adult in 54 participants. Completed in 30 April 2021.
30 April 2021
Quick facts
| Lead sponsor | University of South Carolina |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 54 |
| Start date | 5 February 2020 |
| Primary completion | 30 April 2021 |
| Estimated completion | 30 April 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Motor Sequence Task
Conditions studied
- Adult — all drugs for Adult →
Sponsor
University of South Carolina
Who can join
Adults 18 to 40, any sex, with Adult. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Feedback delivered during motor practice can help promote motor skill learning and promote confidence. However, the optimal way to provide feedback to promote learning and confidence is unknown. This project will study how the feedback that is provided during practice of a movement skill can help people learn and build confidence. The investigators will measure motor skill performance and confidence before and after a session of motor practice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04270448
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Motor Sequence Task
Trials testing the same drug.
- NCT04971486 — Feedback, Motor Sequence Learning, and Brain Connectivity · NA · completed
Other recruiting trials for Adult
Currently open trials in the same condition.
- NCT07354607 — Effect of Transcutaneous Electrical Stimulation on Peripheral Blood Flow · NA · recruiting
- NCT07163728 — Leptin: A Marker for AML Chemo-Sensitivity · recruiting
- NCT07035171 — CABGpreHAB - a Feasibility Study Protocol · NA · recruiting
- NCT07018518 — PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma · Phase 1 · recruiting
- NCT06883149 — PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor · Phase 1 · recruiting
Other University of South Carolina trials
Trials by the same sponsor.
- NCT06469749 — Theory-based Social Media Intervention for Non-medical Use of Prescription Opioids in Young Adults · NA · not yet recruiting
- NCT07340580 — Implementation Facilitation of Exercise is Medicine Greenville · NA · not yet recruiting
- NCT07518407 — Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy · NA · not yet recruiting
- NCT07340099 — Church Implementation of a Social Support Intervention to Increase Physical Activity in Older African American Adults · NA · not yet recruiting
- NCT06024317 — Leveraging Community Health Workers and a Digital Health System to Improve the Timeliness of Child Well Visits · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04270448 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of South Carolina
- Last refreshed: 20 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04270448.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing